Why the study?
Do established cardiovascular risk scores (PROCAM, SCORE, Framingham) correlate with plaque progression measured by serial IVUS in patients with established atherosclerosis?
Population
56 patients with established atherosclerosis in left main coronary arteries
Design
Cohort
Follow-up
18+/-9 months
Authors
Loading...
Risk scores may stratify progression risk in secondary prevention; extends validation to serial IVUS but leaves open therapeutic implications.
Do established cardiovascular risk scores (PROCAM, SCORE, Framingham) correlate with plaque progression measured by serial IVUS in patients with established atherosclerosis?
Established primary prevention risk scores (PROCAM, SCORE, Framingham) correlate linearly with plaque progression measured by serial IVUS in patients with established atherosclerosis.
Birgelen et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: